CAVE CREEK, AZ--(NewMediaWire - Jan 25, 2017) - InvestorsHub
Newswire - Endexx Corporation (OTC
PINK: EDXC), a provider of innovative phyto-nutrient based
food and nutritional products, is pleased to announce today the
commencement of its production to deliver 30,000 units of its
Cannabidiol (CBD) -infused gourmet tea beverages. Endexx's first
product launch Third Eye Chai™, a masala chai tea will be available
in pillow brew bags for individual use in multi-packs.
According to Transparency Market Research, "In 2013, the global
tea market was worth US$38.84 bn and is projected to reach a
valuation of US$47.20 bn by the end of 2020. The market is expected
to exhibit a 2.80% CAGR between 2014 and 2020." According to market
research firm Packaged Facts, it estimates that by 2020 retail
sales of tea in the U.S. will reach almost $9 billion.
Todd Davis, CEO of Endexx, stated, "Tea drinkers are a large
segment of the population and tea sales are in the multi-billions
per year. We believe that Third Eye Chai™ will be a nice addition
to the CBD Unlimited product selection and beneficial to the
consumer. The first batch will be over 150 lbs., and will produce
30 thousand tea bags. We have completed the processing and testing
phase. The batch has been prepared and is headed to production,
with anticipated completion by early March. The Mad Hatter Coffee
& Tea Co., is a brand known for its cannabis-infused tea
beverages for the legal Marijuana industry and is a great partner
and fit for us. We've already received huge demand for our "Chai
Tea CBD"© and the reception has been phenomenal."
In May 2016, Endexx announced a license and distribution
agreement with The Mad Hatter Coffee & Tea Co., to deliver
Cannabidiol (CBD) rich beverages that will be available globally.
The Mad Hatter Coffee & Tea Co. has led the niche market of
cannabis-infused gourmet organic coffee and tea beverages since
2007, and is a true pioneer in cannabis-infused edible brands with
beverage products currently available in 7 legalized states and
over 2000 stores in the U.S. The Mad Hatter has been profiled by
Newsweek, Time, The New York Times, and other major
publications.
About Endexx
Endexx, with its collaborative partners and medical industry
consultants, develops and distributes several consumable product
lines derived from industrial hemp, which is organic and naturally
rich in phytocannabinoids. Phyto-Bites®, is its CBD-infused soft
chews for dogs. The dog treats are formulated to promote health and
support the reduction of separation anxiety, pain and
inflammation. The company also has two technology products and
services that launched in 2014 -- the M3hub and the Autospense™.
Both products provide essential solutions to promote regulatory
compliance and full accountability through inventory management and
an "End of Sale" technology integration. Based on principles
developed by the pharmacological industry, the m3hub platform is
the first standardized software solution that maintains compliance
with federal, state and local regulations. It is intended to
provide a smooth transition to eventual federal mandates. The
Autospense™ is a commercial grade inventory control and dispensing
device that provides up-to-the-minute accounting details and
ensures both product and patient security. By automating the
dispensing process, Autospense™ increases productivity and reduces
costs for retailers, while enhancing their service quality by
reducing transaction time for customers. Websites
include: www.cbdunlimited.com and www.m3hub.com
Safe Harbor Notice
This press release may contain "forward-looking statements"
within the meaning of the Private Securities Litigation Reform Act
of 1995, such as statements relating to financial results and plans
for future development activities, and are thus prospective.
Forward-looking statements include all statements that are not
statements of historical fact regarding intent, belief or current
expectations of the Company, its directors or its officers.
Investors are cautioned that any such forward-looking statements
are not guarantees of future performance and involve risks and
uncertainties, many of which are beyond the Company's ability to
control. Actual results may differ materially from those projected
in the forward-looking statements. Among the factors that could
cause actual results to differ materially from those indicated in
the forward-looking statements are risks and uncertainties
associated with the Company's business and finances in general,
including the ability to continue and manage its growth,
competition, global economic conditions and other factors discussed
in detail in the Company's periodic filings with the Security and
Exchange Commission. The Company undertakes no obligation to update
any forward-looking statements.